1. Home
  2. GXO vs RGEN Comparison

GXO vs RGEN Comparison

Compare GXO & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GXO
  • RGEN
  • Stock Information
  • Founded
  • GXO 2021
  • RGEN 1981
  • Country
  • GXO United States
  • RGEN United States
  • Employees
  • GXO N/A
  • RGEN N/A
  • Industry
  • GXO Transportation Services
  • RGEN Medical/Dental Instruments
  • Sector
  • GXO Consumer Discretionary
  • RGEN Health Care
  • Exchange
  • GXO Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • GXO 6.1B
  • RGEN 6.5B
  • IPO Year
  • GXO N/A
  • RGEN N/A
  • Fundamental
  • Price
  • GXO $53.93
  • RGEN $148.84
  • Analyst Decision
  • GXO Strong Buy
  • RGEN Buy
  • Analyst Count
  • GXO 13
  • RGEN 11
  • Target Price
  • GXO $62.62
  • RGEN $167.90
  • AVG Volume (30 Days)
  • GXO 903.0K
  • RGEN 933.5K
  • Earning Date
  • GXO 11-04-2025
  • RGEN 11-11-2025
  • Dividend Yield
  • GXO N/A
  • RGEN N/A
  • EPS Growth
  • GXO N/A
  • RGEN N/A
  • EPS
  • GXO 0.53
  • RGEN N/A
  • Revenue
  • GXO $12,683,000,000.00
  • RGEN $673,956,000.00
  • Revenue This Year
  • GXO $13.70
  • RGEN $16.77
  • Revenue Next Year
  • GXO $6.38
  • RGEN $13.79
  • P/E Ratio
  • GXO $101.42
  • RGEN N/A
  • Revenue Growth
  • GXO 22.39
  • RGEN 8.73
  • 52 Week Low
  • GXO $30.46
  • RGEN $102.97
  • 52 Week High
  • GXO $63.33
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • GXO 56.22
  • RGEN 66.45
  • Support Level
  • GXO $53.32
  • RGEN $144.07
  • Resistance Level
  • GXO $55.86
  • RGEN $152.30
  • Average True Range (ATR)
  • GXO 1.51
  • RGEN 5.57
  • MACD
  • GXO 0.20
  • RGEN 2.24
  • Stochastic Oscillator
  • GXO 72.29
  • RGEN 86.50

About GXO GXO Logistics Inc.

GXO Logistics Inc is a contract logistics company. Its revenue is diversified across numerous verticals and customers, including many multinational corporations. It provides warehousing and distribution, order fulfillment, e-commerce, reverse logistics, and other supply chain services differentiated by its ability to deliver technology-enabled, customized solutions at scale. Geographically, it generates revenue from the United Kingdom, the United States, the Netherlands, France, Spain, Italy, and other countries, and derives the majority of its revenue from the United Kingdom.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: